Implication of species change of Nontuberculous Mycobacteria during or after treatment

Abstract Background Co-existence or subsequent isolation of multiple nontuberculous mycobacteria (NTM) species in same patient has been reported. However, clinical significance of these observations is unclear. The aim of this study was to determine clinical implications of changes of NTM species du...

Full description

Bibliographic Details
Main Authors: Jong Sik Lee, Jong Hyuk Lee, Soon Ho Yoon, Taek Soo Kim, Moon-Woo Seong, Sung Koo Han, Jae-Joon Yim
Format: Article
Language:English
Published: BMC 2017-12-01
Series:BMC Pulmonary Medicine
Subjects:
Online Access:http://link.springer.com/article/10.1186/s12890-017-0539-7
id doaj-f37138ad76374ea2a5eb3dfa58d4dbcc
record_format Article
spelling doaj-f37138ad76374ea2a5eb3dfa58d4dbcc2020-11-24T22:01:47ZengBMCBMC Pulmonary Medicine1471-24662017-12-011711710.1186/s12890-017-0539-7Implication of species change of Nontuberculous Mycobacteria during or after treatmentJong Sik Lee0Jong Hyuk Lee1Soon Ho Yoon2Taek Soo Kim3Moon-Woo Seong4Sung Koo Han5Jae-Joon Yim6Division of Pulmonary and Critical Care Medicine, Department of Internal Medicine, Seoul National University College of MedicineDepartment of Radiology, Seoul National University College of MedicineDepartment of Radiology, Seoul National University College of MedicineDepartment of Laboratory Medicine, Seoul National University HospitalDepartment of Laboratory Medicine, Seoul National University HospitalDivision of Pulmonary and Critical Care Medicine, Department of Internal Medicine, Seoul National University College of MedicineDivision of Pulmonary and Critical Care Medicine, Department of Internal Medicine, Seoul National University College of MedicineAbstract Background Co-existence or subsequent isolation of multiple nontuberculous mycobacteria (NTM) species in same patient has been reported. However, clinical significance of these observations is unclear. The aim of this study was to determine clinical implications of changes of NTM species during or after treatment in patients with NTM lung disease. Methods Patients with NTM lung disease, who experienced changes of NTM species during treatment or within 2 years of treatment completion between January 1, 2009 and December 31, 2015, were included in the analysis. Demographic, clinical, microbiological, and radiographic data were reviewed and analyzed. Results During the study period, 473 patients were newly diagnosed with NTM lung disease. Treatment was started in 164 patients (34.6%). Among these 164 patients, 16 experienced changes of NTM species during or within 2 years of treatment completion. Seven showed changes from M. avium complex (MAC) to M. abscessus subspecies abscessus (MAA) and five patients displayed changes from M. abscessus subspecies massiliense (MAM) to MAC. With isolation of new NTM species, 6 out of 7 patients with change from MAC to MAA reported worsening of symptoms, whereas none of the five patients with change from MAM to MAC reported worsening of symptoms. All MAA isolated during or after treatment for MAC lung diseases showed inducible resistance to clarithromycin. Conclusions Change of NTM species may occur during or after treatment for NTM lung disease. Especially, changes from MAC to MAA is accompanied by symptomatic and radiographic worsening as well as inducible resistance to clarithromycin.http://link.springer.com/article/10.1186/s12890-017-0539-7Nontuberculous mycobacteria species changeMycobacterium avium ComplexMycobacterium abscessus subspecies abscessusClarithromcycin resistance
collection DOAJ
language English
format Article
sources DOAJ
author Jong Sik Lee
Jong Hyuk Lee
Soon Ho Yoon
Taek Soo Kim
Moon-Woo Seong
Sung Koo Han
Jae-Joon Yim
spellingShingle Jong Sik Lee
Jong Hyuk Lee
Soon Ho Yoon
Taek Soo Kim
Moon-Woo Seong
Sung Koo Han
Jae-Joon Yim
Implication of species change of Nontuberculous Mycobacteria during or after treatment
BMC Pulmonary Medicine
Nontuberculous mycobacteria species change
Mycobacterium avium Complex
Mycobacterium abscessus subspecies abscessus
Clarithromcycin resistance
author_facet Jong Sik Lee
Jong Hyuk Lee
Soon Ho Yoon
Taek Soo Kim
Moon-Woo Seong
Sung Koo Han
Jae-Joon Yim
author_sort Jong Sik Lee
title Implication of species change of Nontuberculous Mycobacteria during or after treatment
title_short Implication of species change of Nontuberculous Mycobacteria during or after treatment
title_full Implication of species change of Nontuberculous Mycobacteria during or after treatment
title_fullStr Implication of species change of Nontuberculous Mycobacteria during or after treatment
title_full_unstemmed Implication of species change of Nontuberculous Mycobacteria during or after treatment
title_sort implication of species change of nontuberculous mycobacteria during or after treatment
publisher BMC
series BMC Pulmonary Medicine
issn 1471-2466
publishDate 2017-12-01
description Abstract Background Co-existence or subsequent isolation of multiple nontuberculous mycobacteria (NTM) species in same patient has been reported. However, clinical significance of these observations is unclear. The aim of this study was to determine clinical implications of changes of NTM species during or after treatment in patients with NTM lung disease. Methods Patients with NTM lung disease, who experienced changes of NTM species during treatment or within 2 years of treatment completion between January 1, 2009 and December 31, 2015, were included in the analysis. Demographic, clinical, microbiological, and radiographic data were reviewed and analyzed. Results During the study period, 473 patients were newly diagnosed with NTM lung disease. Treatment was started in 164 patients (34.6%). Among these 164 patients, 16 experienced changes of NTM species during or within 2 years of treatment completion. Seven showed changes from M. avium complex (MAC) to M. abscessus subspecies abscessus (MAA) and five patients displayed changes from M. abscessus subspecies massiliense (MAM) to MAC. With isolation of new NTM species, 6 out of 7 patients with change from MAC to MAA reported worsening of symptoms, whereas none of the five patients with change from MAM to MAC reported worsening of symptoms. All MAA isolated during or after treatment for MAC lung diseases showed inducible resistance to clarithromycin. Conclusions Change of NTM species may occur during or after treatment for NTM lung disease. Especially, changes from MAC to MAA is accompanied by symptomatic and radiographic worsening as well as inducible resistance to clarithromycin.
topic Nontuberculous mycobacteria species change
Mycobacterium avium Complex
Mycobacterium abscessus subspecies abscessus
Clarithromcycin resistance
url http://link.springer.com/article/10.1186/s12890-017-0539-7
work_keys_str_mv AT jongsiklee implicationofspecieschangeofnontuberculousmycobacteriaduringoraftertreatment
AT jonghyuklee implicationofspecieschangeofnontuberculousmycobacteriaduringoraftertreatment
AT soonhoyoon implicationofspecieschangeofnontuberculousmycobacteriaduringoraftertreatment
AT taeksookim implicationofspecieschangeofnontuberculousmycobacteriaduringoraftertreatment
AT moonwooseong implicationofspecieschangeofnontuberculousmycobacteriaduringoraftertreatment
AT sungkoohan implicationofspecieschangeofnontuberculousmycobacteriaduringoraftertreatment
AT jaejoonyim implicationofspecieschangeofnontuberculousmycobacteriaduringoraftertreatment
_version_ 1725838506863886336